HTHT Price Prediction Next Week
Technical Analysis
Recent price action shows HTHT in a downward trend, with significant selling pressure. The stock has broken below key support levels and shows bearish momentum based on technical indicators.
News Impact
Recent analyst actions and news have been predominantly negative:
- HSBC downgraded HTHT to Hold from Buy with a $32.40 price target on February 4, 2025
- The stock showed weakness in recent ETF trading, declining about 2.1% in early January
Price Prediction for Next Week (March 3-7, 2025)
Based on technical analysis and recent news sentiment:
Target Prices:
- Resistance: $33.50
- Support: $30.20
- Most Likely Range: $31.00-$32.50
The stock is likely to continue its downward trend in the coming week, with a predicted closing price of $31.20 by end of week. This represents approximately a 2% decline from current levels.
Trading Recommendation
SELL with the following parameters:
- Entry: Current market price
- Stop Loss: $33.80
- First Target: $31.20
- Second Target: $30.20
The bearish outlook is supported by:
- Recent analyst downgrade
- Negative technical momentum
- Weak performance in broader China-related stocks
- Deteriorating market sentiment
HTHT Similar Chart Price Prediction
The price of HTHT is predicted to go up -0.94%, based on the high correlation periods with TWO. The similarity of these two price pattern on the periods is 97.43%.
HTHT
TWO
Down: -0.94%Similarity: 97.43%
HTHT Revenue Forecast
HTHT EPS Forecast
HTHT FAQs
What is bull’s view on HTHT?
What is bear's view on HTHT?
What is HTHT revenue forecast for next quarter？
What is HTHT eps forecast for next quarter？
HTHT Analyst's Forecast
Fawne Jiang
Benchmark
Strong Buy
2024-11-27
Price Target
$53 → $48
Upside
+49.86%
Benchmark analyst Fawne Jiang lowered the firm's price target on H World to $48 from $53 and keeps a Buy rating on the shares after the company reported Q3 revenue and adjusted EBITDA that fell below expectation, primarily driven by larger than expected RevPAR declines. For FY25, the firm now forecasts year-over-year revenue growth of 5%, down from a 7% prior view, and adjusted EBITDA growth of 14%, down from 15% forecast previously, driving its lowered price target.
